Cipla subsidiary acquires Celeris

Posted By:

Pharma major, Cipla in a notice to the Bombay Stock Exchange has said that Cipla Holding B.V., a wholly owned subsidiary of the Company, has acquired 100 per cent stake in Celeris d.o.o., Croatia.

Celeris d.o.o. is the distributor of Company's products in Croatia. Cipla Ltd is one of the world's largest generic companies. The company has over 2,000 products, 65 therapeutic categories, over 40 dosage forms. The company has 34 state-of-the-art manufacturing facilities approved by major international regulatory agencies.

The stock of Cipla was trading marginally higher at Rs 393 on the Bombay Stock Exchange.

Read more about: cipla, celeris
Please Wait while comments are loading...
Company Search
Enter the first few characters of the company's name or the NSE symbol or BSE code and click 'Go'

Thousands of Goodreturn readers receive our evening newsletter.
Have you subscribed?